Latest S-1 registration statements

Accelerate Diagnostics plans to offer 4,500,000 units, each with a share of common stock and a warrant, along with pre-funded units for certain investors.

Calidi Biotherapeutics files an amendment to its registration statement related to the issuance of common stock upon warrant exercises and resale by selling securityholders.

Collective Audience, Inc. has filed a registration statement for the resale of up to 3,223,042 shares of its common stock by selling securityholders.

Soligenix, a late-stage biopharmaceutical company, announces a proposed public offering to raise up to $10 million through the sale of common stock and warrants.

Athena Bitcoin Global files an amendment to its registration statement for the resale of up to 444,583,937 shares of common stock by selling shareholders, while navigating a complex and evolving regulatory landscape.

Cingulate Inc. plans to offer shares of common stock, Series A warrants, Series B warrants, and pre-funded warrants in a public offering.

Healthcare Triangle is registering up to 12.1 million common shares for potential resale by a selling stockholder after a recent private placement involving convertible notes and warrants.

ABVC BioPharma is registering for the resale of over 10 million shares of its common stock by selling stockholders, as detailed in a recent S-1 filing.

Ozop Energy Solutions intends to offer up to 1,000,000,000 shares of common stock through an equity financing agreement with GHS Investments LLC.

Alto Neuroscience, a clinical-stage biopharmaceutical company, has filed for an IPO to advance its precision psychiatry platform and pipeline of personalized treatments for mental health conditions.

Lucy Scientific Discovery has filed a registration statement for the potential resale of up to 7,361,688 common shares by selling stockholders.

Microbot Medical has filed a registration statement for the potential resale of up to 1,769,966 shares of its common stock, issuable upon the exercise of outstanding preferred investment options held by selling stockholders.

FibroBiologics updates its registration statement for a direct listing on the Nasdaq Global Market, detailing the resale of common stock by existing stockholders.

BKV Corporation appoints Mary Rita Valois as its Chief Information Officer, effective October 9, 2023.

Volato Group has filed a registration statement for the potential resale of up to 23.3 million shares of common stock and associated warrants by selling stockholders.

Kaival Brands is registering the distribution of 1.8 million shares of common stock and warrants to purchase common stock to GoFire's stockholders, stemming from a prior asset acquisition.

Blue Star Foods Corp. has filed an amendment to its registration statement for the potential offer and resale of up to 19,876,735 shares of its common stock by selling stockholders.

Save Foods Inc. is registering for resale up to 6,666,667 shares of its common stock by YA II PN, Ltd., according to a Form S-1 filing.

Titan Environmental Solutions Inc., formerly TraQiQ, Inc., reincorporated in Nevada and is pursuing a listing on the NYSE American following a public offering.

TransCode Therapeutics is seeking to raise up to $7.5 million through a public offering of common stock and warrants to advance its oncology-focused RNA therapeutic programs.

Interactive Strength Inc. has filed a registration statement for the resale of up to 4,284,146 shares of its common stock by Tumim Stone Capital, LLC, pursuant to an equity line purchase agreement.

Evoke Pharma is launching an offering of common stock and pre-funded warrant units to raise approximately $6.3 million for working capital and general corporate purposes.